Growth Metrics

Omeros (OMER) Interest Coverage Ratio Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 15.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -303.06%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 18.06%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,150.63%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 69.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.11%
Dec 31, 2025 68.26%
Sep 30, 2025 122.62%
Jun 30, 2025 -33,498.97%
Mar 31, 2025 -101.80%
Dec 31, 2024 -86.48%
Sep 30, 2024 -43.65%
Jun 30, 2024 -24.50%
Mar 31, 2024 -5.34%
Dec 31, 2023 -10.85%
Sep 30, 2023 40.90%
Jun 30, 2023 32.14%
Mar 31, 2023 36.53%
Dec 31, 2022 41.37%
Sep 30, 2022 -26.92%
Jun 30, 2022 18.20%
Mar 31, 2022 23.31%
Dec 31, 2021 -104.63%
Sep 30, 2021 -119.49%
Jun 30, 2021 -100.62%
Mar 31, 2021 -130.58%
Dec 31, 2020 -3.78%
Sep 30, 2020 -90.22%
Jun 30, 2020 -174.21%
Mar 31, 2020 -16.75%
Dec 31, 2019 -13.67%
Sep 30, 2019 74.78%
Jun 30, 2019 79.73%
Mar 31, 2019 64.95%
Dec 31, 2018 27.22%
Sep 30, 2018 -318.98%
Jun 30, 2018 -89.96%
Mar 31, 2018 -105.12%
Dec 31, 2017 -1.96%
Sep 30, 2017 67.40%
Jun 30, 2017 25.50%
Mar 31, 2017 66.22%
Dec 31, 2016 78.34%
Sep 30, 2016 74.56%
Jun 30, 2016 65.46%
Mar 31, 2016 24.49%
Dec 31, 2015 -2.27%
Sep 30, 2015 -22.10%
Jun 30, 2015 7.06%
Mar 31, 2015 19.72%
Dec 31, 2014 6.09%
Sep 30, 2014 20.03%
Jun 30, 2014 17.94%
Mar 31, 2014 -36.73%
Dec 31, 2013 -13.88%
Sep 30, 2013 28.11%
Jun 30, 2013 -22.77%
Mar 31, 2013 -4.47%
Dec 31, 2012 -11.12%
Sep 30, 2012 -170.37%
Jun 30, 2012 -93.79%
Mar 31, 2012 25.77%
Dec 31, 2011 33.02%
Sep 30, 2011 43.58%
Jun 30, 2011 49.69%